QUOTED. 8 January 2020. Lucien Goffart.
French company Robocath expects its R-One robotic-assistance platform to make interventional cardiology more efficient and safer for interventionalists. See what company CEO Lucien Goffart said about “momentum in vascular robots” here.
"There is a clear momentum in vascular robots, and so we are clearly attractive [to investors] and feel comfortable about getting enough money to develop the next generation [system].” – Lucien Goffart, CEO, Robocath
Click here for a free trial of Medtech Insight